Retraction: Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma
Oncotarget
.
2024 Oct 11:15:725.
doi: 10.18632/oncotarget.28663.
Authors
Valerie B Sampson
1
,
Nancy S Vetter
1
,
Wendong Zhang
2
,
Pratima U Patil
3
,
Robert W Mason
3
,
Erika George
4
,
Richard Gorlick
2
,
Edward A Kolb
1
Affiliations
1
Cancer Therapeutics Laboratory, Nemours Center for Cancer and Blood Disorders, Nemours/A.I. duPont Hospital for Children, Wilmington, DE, USA.
2
Department of Pediatrics - Hematology and Oncology, The Children's Hospital at Montefiore, The Albert Einstein College of Medicine, Bronx, NY, USA.
3
Nemours Center for Childhood Cancer Research, Alfred I. duPont Hospital for Children, Wilmington, DE, USA.
4
Department of Biological Sciences, University of Delaware, Newark, DE, USA.
PMID:
39392376
PMCID:
PMC11468389
DOI:
10.18632/oncotarget.28663
No abstract available
Publication types
Retraction of Publication